Klaria Pharma Holding AB Logo

Klaria Pharma Holding AB

Develops oral films for non-invasive drug delivery as an alternative to injections and sprays.

KLAR | ST

Overview

Corporate Details

ISIN(s):
SE0007280326
LEI:
529900YLMSNHNP7HOD11
Country:
Sweden
Address:
Virdings Allé 2, 754 50 UPPSALA
Sector:
Manufacturing
Industry:
Manufacture of pharmaceuticals, medicinal chemical and botanical products

Description

Klaria Pharma Holding AB is a pharmaceutical company that develops novel drug products based on its patented, proprietary alginate-based oral transmucosal film technology. This platform delivers active pharmaceutical ingredients directly into the bloodstream by adhering to the inside of the cheek, providing a non-invasive alternative to treatments currently available only as injections or nasal sprays. The company's strategy focuses on addressing significant patient needs where its technology offers clear advantages, such as improved convenience, safety, and efficacy. Klaria's development pipeline includes treatments for migraine (Sumatriptan), severe allergic reactions (Epinephrine), and organ transplant rejection (Sirolimus). The company also operates a subsidiary, Cannabis Delivery Sciences, which applies the film technology to cannabinoid-based products.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Klaria Pharma Holding AB filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Need More History? Access decades of standardized financials for Klaria Pharma Holding AB via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
Hana Pharm. Co., Ltd. Logo
Pharmaceutical firm specializing in anesthetics and narcotic analgesics for global markets.
South Korea 293480
Hanmi Pharm. Co., Ltd. Logo
Biopharma firm developing innovative diabetes and cancer drugs for patients and professionals.
South Korea 128940
Hansa Biopharma Logo
Develops antibody-cleaving enzymes to treat rare diseases and enable organ transplants.
Sweden HNSA
HEALIOS K.K. Logo
Develops iPS and somatic stem cell therapies for diseases like ARDS and cancer.
Japan 4593
Heartseed株式会社 Logo
Develops iPSC-derived cell therapies to regenerate heart tissue for heart failure.
Japan 219A
HELLENIC DYNAMICS PLC Logo
Cultivates and supplies THC-dominant medical cannabis for the European pharmaceutical market.
United Kingdom HELD
HEMOGENYX PHARMACEUTICALS PLC Logo
Develops CAR-T therapies for blood cancers, autoimmune disorders, and viral infections.
United Kingdom HEMO
HEM Pharma Inc. Logo
Microbiome biotech using analysis for personalized probiotics, LBPs, and full CDMO services.
South Korea 376270
Hemp Health Spolka Akcyjna Logo
A vertically integrated supplier of medical cannabis raw material for the Polish market.
Poland HMP
Herantis Pharma Oyj Logo
Developing disease-modifying therapies for neurodegenerative conditions like Parkinson's disease.
Finland HRTIS

Talk to a Data Expert

Have a question? We'll get back to you promptly.